Shortcut to Body Shortcut to main menu

Find Korean Companies

  • Home
  • Investment Opportunities
  • Find Korean Companies
  • Company
  • Business Sector
  • Key products and services
    Drug Development: MT101(Parkinson's Disease), MT102(Inflammatory Bowel Disease)
  • Brochure
    [MTHERA] IR DECK 2022_short.pdf [View] [Download]
  • Corporate Video
  • Company Profile
     Company Description/Summary
    MTHERAPHARMA Co., Ltd. is a biopharmaceutical company focused on developing innovative multi-target driven-disease modifying therapeutics for chronic incurable diseases.
    We have Symthomics as MTHERA's platform technology to accelerate the discovery of multi-target drug candidates by MTHERA-CODA system (AI-based in silico system) and the most cutting-edge technology of multi-omics integration, systems biology and bioinformatics.
    For therapeutic consistency, we have established CMC technology to satisfy totality of evidence required for the global standard of Regulatory Authorities (FDA & EMA) from raw materials to final product.
    We are pioneering multimodal botanical drugs that simultaneously improve the various causes of disease to address unmet medical needs.